Panobinostat
ACCT008/ASSG35
Phase 2 small_molecule terminated
Quick answer
Panobinostat for Rhabdoid Tumor is a Phase 2 program (small_molecule) at Zealand Pharma A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Zealand Pharma A/S
- Indication
- Rhabdoid Tumor
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated